News

MIDCAP PARTNERS has successfully accompanied the IPO of THERANEXUS

MIDCAP PARTNERS is delighted to have successfully accompanied the IPO of THERANEXUS...
Read more

MIDCAP PARTNERS: Co-Lead Manager in a 120M€ placement of Solutions 30 shares

Midcap partners acted as Co-lead Manager in the Secondary Offering of 4 700 000...
Read more

Les Echos.fr – Un cabinet d’analystes très emballé par le dossier

Pour les analystes de Midcap Partners, cette société de biotechnologie vaut deux...
Read more

MIDCAP PARTNERS accompanies Global Bioenergies in its €10M placement

Global Bioenergies is pleased with the success of its private placement with French...
Read more

MIDCAP PARTNERS accompanies Medicrea in its €13M placement

MIDCAP PARTNERS is proud to have accompanied Medicrea as Lead Manager and Bookrunner...
Read more

Corporate finance

Midcap Partners is an independent actor capable of accompanying
you in resolving all your financing and shareholding issues.
We have an objective: to optimise value creation for the entrepreneur!

Learn more

BROKERAGE SERVICES

Midcap Partners is a tied agent of Louis Capital Markets in order to offer its institutional investor and issuer clients high quality infrastructures in several asset classes listed on three continents (Paris/London, New York and Hong Kong).

Learn more

Corporate Broking

The teams at Midcap Partners pay very special attention to post-listing follow-up which is only
the first step of a life on the stock market. Valuation and financing capacity work
continuously in a long-term relationship of trust.

Learn more

Research

Financial research and analysis are at the heart of our approach to companies, as much at the secondary as at the primary level. Curiosity, rigour, humility and passion are the values which motivate our team of dedicated small-mid caps analysts. Because each company is unique we reject all quantitative systems in order to focus on the particularities of a group and its sector.

Operations
Secondary Offering €10,6M October 2017
Initial Public Offering €19,6M October 2017
Secondary offering €122M October 2017
Transfer on Euronext Growth via a €5M Private Placement September 2017
Acquisition of Bertin Pharma’s assets August 2017
Capital Increase July 2017
Capital increase June 2017
Capital increase June 2017
Capital increase May 2017
Secondary Offering €10M May 2017
Capital increase 399M€ February 2017
Secondary Offering €8.5M November 2016
Capital increase €70M October 2016
Capital increase €12M June 2016
Capital increase €96M February 2016
Initial Public Offering €13M February 2016
Capital increase December 2015
Capital increase €9M October 2015
Initial Public Offering €10,4M June 2015
Initial Public Offering €24M March 2015
M&A December 2014
Initial Public Offering €13M April 2014
Capital increase €4,6M February 2014
Secondary Offering €6M February 2014
Secondary Offering €32M January 2014
Initial Public Offering €17,5M December 2013
Capital Increase €3,5M November 2013
Midcap Partners is appointed representative of Louis Capital Markets
0
Million euros raised
0
Recommendations since January 1st 2015
0
Meetings organised since 1 January 2015
0
Analyses downloaded

THEY TRUST US